Advances in metabolism

Metabolism: Clinical and Experimental

Volumn 62, Issue 12, 2013, Pages 1700-1713

  Tsoukas, Michael A ^a   Farr, Olivia M ^a   Mantzoros, Christos S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE INHIBITOR; ADIPOCYTOKINE; ALBUMIN; ANDROGEN; APOLIPOPROTEIN C2; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DECTIN 1; DIPEPTIDYL PEPTIDASE IV INHIBITOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 21; FIBRONECTIN; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LEPTIN; LEUCINE; LIRAGLUTIDE; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PROTEIN KINASE C IOTA; RESVERATROL; SOMATOMEDIN BINDING PROTEIN 1; SUPEROXIDE DISMUTASE; TELMISARTAN; TOLL LIKE RECEPTOR 3; TRANS FATTY ACID; TRIACYLGLYCEROL; TYROSINE;

ABDOMINAL OBESITY; ADRENAL DISEASE; AEROBIC EXERCISE; ALBUMINURIA; ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CARBOHYDRATE DIET; CARDIOVASCULAR RISK; CATECHOLAMINE URINE LEVEL; CELL RESPIRATION; CHILDHOOD; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENDOTHELIAL DYSFUNCTION; FATTY LIVER; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENOTYPING TECHNIQUE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INNATE IMMUNITY; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; KIDNEY INJURY; LIPOPROTEIN METABOLISM; LOW FAT DIET; MALIGNANT NEOPLASTIC DISEASE; METABOLIC SYNDROME X; MITOCHONDRIAL RESPIRATION; MORTALITY; NEUROSCIENCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PLEIOTROPY; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVIEW; SODIUM RESTRICTION; SUBSTITUTION THERAPY;

EID: 84888000615     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.09.003     Document Type: Editorial

References (84)

1. J.S. Yudkin, I. Juhan-Vague, and E. Hawe Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study Metabolism 53 7 2004 852 857
2. J.P. Deslypere Obesity and cancer Metabolism 44 3 1995 24 27
3. E.E. Kershaw, and J.S. Flier Adipose tissue as an endocrine organ J Clin Endocrinol Metab 89 6 2004 2548
4. B.K. Pedersen, and M.A. Febbraio Muscle as an endocrine organ: focus on muscle-derived interleukin-6 Physiol Rev 88 4 2008 1379 1406
5. H. Hendarto, T. Inoguchi, and Y. Maeda GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases Metabolism 61 10 2012 1422 1434
6. F. Younis, Y. Oron, and R. Limor Prophylactic treatment with telmisartan induces tissue-specific gene modulation favoring normal glucose homeostasis in Cohen-Rosenthal diabetic hypertensive rats Metabolism 61 2 2012 164 174
7. P.M. Ribeiro da Silva, T.M. Batista, and R.A. Ribeiro Decreased insulin secretion in islets from protein malnourished rats is associated with impaired glutamate dehydrogenase function: effect of leucine supplementation Metabolism 61 5 2012 721 732
8. W. Kang, H.J. Hong, J. Guan, and D.G. Kim Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents Metabolism 61 3 2012 424 433
9. M.P. Sajan, S. Nimal, and S. Mastorides Correction of metabolic abnormalities in a rodent model of obesity, metabolic syndrome, and type 2 diabetes mellitus by inhibitors of hepatic protein kinase C-I Metabolism 61 4 2012 459 469
10. L.H. Wu, C.C. Huang, and S. Adhikarakunnathu Loss of toll-like receptor 3 function improves glucose tolerance and reduces liver steatosis in obese mice Metabolism 61 11 2012 1633 1645
11. H. Fujita, H. Fujishima, and K. Takahashi SOD1, but not SOD3, deficiency accelerates diabetic renal injury in C57BL/6-Ins2Akita diabetic mice Metabolism 61 12 2012 1714 1724
12. Y. Tabara, H. Osawa, and R. Kawamoto Genotype risk score of common susceptible variants for prediction of type 2 diabetes mellitus in Japanese: the Shimanami Health Promoting Program (J-SHIPP Study): development of type 2 diabetes mellitus and genotype risk score (Nov 2011) Metabolism 60 11 2011 1634 1640
13. M. Daimon, T. Oizumi, and S. Karasawa Association of the clusterin gene polymorphisms with type 2 diabetes mellitus Metabolism 60 6 2011 815 822
14. N. Cortez-Espinosa, M.H. García-Hernández, and E. Reynaga-Hernández Abnormal expression and function of dectin-1 receptor in type 2 diabetes mellitus patients with poor glycemic control (HbA1c > 8%) Metabolism 61 11 2012 1538 1546
15. N.T. Bendsen, S.B. Haugaard, and T.M. Larsen Effect of trans-fatty acid intake on insulin sensitivity and intramuscular lipids - a randomized trial in overweight postmenopausal women Metabolism 60 7 2011 906 913
16. R. Garg, G.H. Williams, and S. Hurwitz Low-salt diet increases insulin resistance in healthy subjects Metabolism 60 7 2011 965 968
17. K.A. McAuley, J.E. Berkeley, and P.D. Docherty The dynamic insulin sensitivity and secretion test - a novel measure of insulin sensitivity Metabolism 60 12 2011 1748 1756
18. K. Gokulakrishnan, K. Velmurugan, and S. Ganesan Circulating levels of insulin-like growth factor binding protein-1 in relation to insulin resistance, type 2 diabetes mellitus, and metabolic syndrome (Chennai Urban Rural Epidemiology Study 118) Metabolism 61 1 2012 43 46
19. W.X. Jian, W.H. Peng, J. Jin, and X.R. Chen Association between serum fibroblast growth factor 21 and diabetic nephropathy Metabolism 61 6 2012 853 859
20. B.A. Gower, L.L. Goree, and P.C. Chandler-Laney A higher-carbohydrate, lower-fat diet reduces fasting glucose concentration and improves β-cell function in individuals with impaired fasting glucose Metabolism 61 3 2012 358 365
21. J.A. Morrison, C.J. Glueck, and P. Wang Childhood risk factors predict cardiovascular disease, impaired fasting glucose plus type 2 diabetes mellitus, and high blood pressure 26 years later at a mean age of 38 years: the Princeton-Lipid Research Clinics Follow-Up Study Metabolism 61 4 2012 531 541
22. C.S. Mantzoros, and J.S. Flier Leptin as a therapeutic agent - trials and tribulations J Clin Endocrinol Metab 85 2000 4000 4002
23. T. Kelesidis, I. Kelesidis, S. Chou, and C.S. Mantzoros Narrative review: the role of leptin in human physiology: emerging clinical applications Ann Intern Med 152 2 2010 93 100
24. C. Heidemann, S. Qi, and R.M. van Dam Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women Ann Intern Med 149 5 2008 307 316
25. S. Blüher, and C.S. Mantzoros Leptin in humans: lessons from translational research Am J Clin Nutr 89 2009 991S 997S
26. S.H. Chou, J.P. Chamberland, and X. Liu Leptin is an effective treatment for hypothalamic amenorrhea Proc Natl Acad Sci USA 108 16 2011 6585 6590
27. N. Mitsiades, K. Pazaitou-Panayiotou, and K.N. Aronis Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studies J Clin Endocrinol Metab 96 12 2011 E2023 E2028
28. C.S. Mantzoros, F. Magkos, and M. Brinkoetter Leptin in human physiology and pathophysiology Am J Physiol Endocrinol Metab 301 4 2011 E567 E584
29. A. Sahin-Efe, F. Katsikeris, and C.S. Mantzoros Advances in adipokines Metabolism 61 12 2012 1659 1665
30. J.Y. Huh, G. Panagiotou, and V. Mougios FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise Metabolism 61 12 2012 1725 1738
31. R.V. Sekhar, F. Jahoor, and D. Iyer Leptin replacement therapy does not improve the abnormal lipid kinetics of hypoleptinemic patients with HIV-associated lipodystrophy syndrome Metabolism 61 10 2012 1395 1403
32. J.H. Lee, J.L. Chan, and E. Sourlas Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy J Clin Endocrinol Metab 91 2006 2605 2611
33. K. Tsubakio-Yamamoto, T. Sugimoto, and M. Nishida Serum adiponectin level is correlated with the size of HDL and LDL particles determined by high performance liquid chromatography Metabolism 61 12 2012 1763 1770
34. Q. Li, Y. Lu, and L. Sun Plasma adiponectin levels in relation to prognosis in patients with angiographic coronaryartery disease Metabolism 61 12 2012 1803 1808
35. J. Hoover-Plow, and M. Huang Lipoprotein(a) metabolism: potential sites for therapeutic targets Metabolism 62 4 2013 479 491
36. A.A. Kei, T.D. Filippatos, V. Tsimihodimos, and M.S. Elisaf A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease Metabolism 61 7 2012 906 921
37. J.P. Corsetti, R.T. Gansevoort, and S.J.L. Bakker Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein Metabolism 61 7 2012 996 1002
38. J.A. Morrison, C.J. Glueck, and S.R. Daniels Determinants of ApoB, ApoA1, and the ApoB/ApoA1 ratio in healthy schoolgirls, prospectively studied from mean ages 10 to 19 years: the Cincinnati National Growth and Health Study Metabolism 61 10 2012 1377 1387
39. Z. Chen, S. Wang, and M.L. Krsmanovic Small molecule activation of lecithin cholesterol acyltransferase modulates lipoprotein metabolism in mice and hamsters Metabolism 61 4 2012 470 481
40. S.S. Kulkarni, F. Salehzadeh, and T. Fritz Mitochondrial regulators of fatty acid metabolism reflect metabolic dysfunction in type 2 diabetes mellitus Metabolism 61 2 2012 175 185
41. S. He, S. Wang, and X. Chen Higher ratio of triglyceride to high-density lipoprotein cholesterol may predispose to diabetes mellitus: 15-year prospective study in a general population Metabolism 61 1 2012 30 36
42. J.L. Jones, M. Comperatore, and J. Barona A Mediterranean-style, low-glycemic-load diet decreases atherogenic lipoproteins and reduces lipoprotein (a) and oxidized low-density lipoprotein in women with metabolic syndrome Metabolism 61 3 2012 366 372
43. T.F. Luscher, and M. Barton Biology of the endothelium Clin Cardiol 20 II 1997 II-3 II-10
44. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
45. M. Terasaki, M. Nagashima, and T. Watanabe Effects of p KF275-055, a dipeptidyl peptidase-4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E-null mice Metabolism 61 7 2012 974 977
46. M.B. Zimering, R.J. Anderson, and L. Ge Increased plasma basic fibroblast growth factor is associated with coronary heart disease in adult type 2 diabetes mellitus Metabolism 60 2 2011 284 291
47. G. Xiang, J. Pu, and L. Yue Lipoic acid can improve endothelial dysfunction in subjects with impaired fasting glucose Metabolism 60 4 2012 480 485
48. G. Zoppini, C. Negri, and V. Stoico Triglyceride-high-density lipoprotein cholesterol is associated with microvascular complications in type 2 diabetes mellitus Metabolism 61 1 2012 22 29
49. M. Creatsa, E. Armeni, and K. Stamatelopoulos Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women Metabolism 61 2 2012 193 201
50. S.J. Hamilton, G.T. Chew, T.M.E. Davis, and G. Watts Prevalence and predictors of abnormal arterial function in statin-treated type 2 diabetes mellitus patients Metabolism 61 3 2012 349 357
51. V.G. Kaklamani, A. Linos, and E. Kaklamani Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults J Clin Oncol 17 10 1999 3291 3298
52. K. Michalakis, C. Williams, and N. Mitsiades Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study Cancer Epidemiol Biomarkers Prev 16 2007 308 313
53. E.E. Calle, C. Rodriguez, and K. Walker-Thurmond Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 2003 1625 1638
54. S.J. Freedland, J. Wen, and M. Wuerstle Obesity is a significant risk factor for prostate cancer at the time of biopsy Urology 72 2008 1102 1105
55. M. Dalamaga, K. Diakopoulos, and C.S. Mantzoros The role of adiponectin in cancer: a review of current evidence Endocr Rev 33 4 2012 547 594
56. H.S. Moon, M. Dalamaga, and S.Y. Kim Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals Endocr Rev 34 2013 377 412
57. H.S. Moon, X. Liu, and J.M. Nagel Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in mice Gut 62 4 2013 561 570
58. V. Kaklamani, N. Yi, and K. Zhang Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk (Sept 2011) Metabolism 60 9 2011 1234 1243
59. S.P. Gialamas, E.T. Petridou, and S. Tseleni-Balafouta Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer Metabolism 60 11 2011 1530 1538
60. E.T. Petridou, T.N. Sergentanis, and C.N. Antonopoulos Insulin resistance: an independent risk factor for lung cancer? Metabolism 60 8 2011 1100 1106
61. D. Baur, J. Klotsche, and O.P. Hamnvik Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort Metabolism 60 10 2011 1363 1371
62. V. Rosato, A. Tavani, and C. Bosetti Metabolic syndrome and pancreatic cancer risk: a case-control study in Italy and meta-analysis Metabolism 60 10 2011 1372 1378
63. Y. Sasaki, H. Takeda, and T. Sato Increased levels of serum glucose-dependent insulinotropic polypeptide as a novel risk factor for human colorectal adenoma Metabolism 60 9 2011 1253 1258
64. L.S. Gorman The adrenal gland: common disease states and suspected new applications Clin Lab Sci 26 2013 118 125
65. J. Choi, J. Park, and G. Kim Functional effects of DAX-1 mutations identified in patients with X-linked adrenal hypoplasia congenita Metabolism 60 11 2011 1545 1550
66. P. Concolino, E. Mello, and M.C. Patrosso p.H282N and p.Y191H: 2 novel CYP21A2 mutations in Italian congenital adrenal hyperplasia patients Metabolism 61 4 2012 519 524
67. P. Utriainen, S. Laakso, J. Jääskeläinen, and R. Voutilainen Polymorphisms of POR, SULT2A1 and HSD11B1 in children with premature adrenarche Metabolism 61 9 2012 1215 1219
68. T. Pappa, K. Vemmos, and K. Saltiki Severity and outcome of acute stroke in women: relation to adrenal sex steroid levels Metabolism 61 1 2012 84 91
69. S. Champaneri, X. Xu, and M.R. Carnethon Diurnal salivary cortisol and urinary catecholamines are associated with diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis Metabolism 61 7 2012 986 995
70. K.W. Williams, and J.K. Elmquist From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior Nat Neurosci 15 2012 1350 1355
71. C. Bjorbaek, and B. Kahn Leptin signaling in CNS and periphery Endocr Rev 59 2004 305 331
72. J.S. Fuqua, and A.D. Rogol Neuroendocrine alterations in the exercising human: implications for energy homeostasis Metabolism 62 7 2013 911 921
73. F. Anan, T. Masaki, and T. Shimomura High-sensitivity C-reactive protein is associated with hippocampus volume in nondementia patients with type 2 diabetes mellitus Metabolism 60 4 2011 460 466
74. T. Masaki, F. Anan, and T. Shimomura Association between hippocampal volume and serum adiponectin in patients with type 2 diabetes mellitus Metabolism 61 8 2012 1197 1200
75. A. Gorgey, K. Mather, and D. Gater Central adiposity associations to carbohydrate and lipid metabolism in individuals with complete motor spinal cord injury Metabolism 60 6 2011 843 851
76. G. Aubert, V. Mansuy, and M.J. Voirol The anorexigenic effects of metformin involve increases in hypothalamic leptin receptor expression Metabolism 60 3 2011 327 334
77. N. Ogawa, M. Ito, and H. Yamaguchi Intestinal fatty acid infusion modulates food preference as well as calorie intake via the vagal nerve and midbrain-hypothalamic neural pathways in rats Metabolism 61 9 2012 1312 1320
78. M.S. Mansour, Y. Ni, and A.L. Roberts Ginger consumption enhances the thermic effect of food and promotes feelings of satiety without affecting metabolic and hormonal parameters in overweight men: a pilot study Metabolism 61 10 2012 1347 1352
79. C.G. Perry, D.A. Kane, I.R. Lanza, and P.D. Neufer Methods for assessing mitochondrial function in diabetes Diabetes 62 4 2013 1041 1053
80. M. Chattopadhyay, I. GuhaThakurta, and P. Behera Mitochondrial bioenergetics is not impaired in nonobese subjects with type 2 diabetes mellitus Metabolism 60 12 2011 1702 1710
81. M. Schoepe, A. Schrepper, and M. Schwarzer Exercise can induce temporary mitochondrial and contractile dysfunction linked to impaired respiratory chain complex activity Metabolism 61 1 2012 117 126
82. L. Fu, X. Liu, and Y. Niu Effects of high-fat diet and regular aerobic exercise on global gene expression in skeletal muscle of C57BL/6 mice Metabolism 61 1 2012 146 152
83. J. Zheng, L. Chen, and H. Zhang Resveratrol improves insulin resistance of catch-up growth by increasing mitochondrial complexes and antioxidant function in skeletal muscle Metabolism 61 7 2012 954 965
84. M.S. Lee, S. Choi, and E. Suk Ha Fibroblast growth factor-21 protects human skeletal muscle myotubes from palmitate-induced insulin resistance by inhibiting stress kinase and NF-kB Metabolism 61 8 2012 1142 1151